login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AEGLEA BIOTHERAPEUTICS INC (AGLE) Stock News
USA
- NASDAQ:AGLE -
US00773J2024
-
Common Stock
12.01
USD
+0.97 (+8.79%)
Last: 11/27/2023, 8:00:00 PM
11.88
USD
-0.13 (-1.08%)
After Hours:
11/27/2023, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AGLE Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Spyre Therapeutics, Inc.
Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Announces Grants of Inducement Awards
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Announces Grants of Inducement Awards
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics to Participate in Upcoming November Investor Conferences
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Announces Grants of Inducement Awards
2 years ago - By: Benzinga
Recap: Aeglea BioTherapeutics Q1 Earnings
2 years ago - By: Aeglea
Aeglea BioTherapeutics to Participate in Upcoming September Conference
2 years ago - By: Benzinga
- Mentions:
CPHI
TRVN
CBAY
SXTC
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Announces Reverse Stock Split
2 years ago - By: Aeglea BioTherapeutics, Inc.
- Mentions:
ARQT
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
2 years ago - By: InvestorPlace
- Mentions:
VHNA
LQR
HE
VFS
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma
2 years ago - By: Seeking Alpha
Aeglea stock initiated with Buy at Stifel (NASDAQ:AGLE)
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Announces Grant of Inducement Awards
2 years ago - By: InvestorPlace
- Mentions:
ONCS
CTM
CFMS
NVVE
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
2 years ago - By: InvestorPlace
- Mentions:
SCHD
AMC
Why Is Aeglea BioTherapeutics (AGLE) Stock Up 392% Today?
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
2 years ago - By: Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics Reports First Quarter 2023 Financial Results
Please enable JavaScript to continue using this application.